AI assistant
AtriCure, Inc. — Director's Dealing 2017
May 9, 2017
31802_dirs_2017-05-09_5b01b871-43a9-44e1-8778-4686b6e5824a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-05-05
Reporting Person: Hooven Michael D (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-05 | Common Stock | S | 10000 | $22.08 | Disposed | 57049 | Direct |
| 2017-05-05 | Common Stock | M | 10000 | $9.50 | Acquired | 67049 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-05 | Stock Option (right to buy) | $9.50 | M | 10000 | Disposed | 2017-06-20 | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 234211 | Indirect |
| Common Stock | 234211 | Indirect |
| Common Stock | 18421 | Indirect |
Footnotes
F1: These shares were sold pursuant to a 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.32 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: These shares were exercised pursuant to a 10b5-1 trading plan.
F4: Held by Michael D. Hooven 2004 Trust FBO Michael. Mr. Hooven disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F5: Held by Michael D. Hooven 2004 Trust FBO Susan. Mr. Hooven disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F6: Held by Susan Spies 2004 Children's Trust. These shares are held in trust for the benefit of the Reporting Person's son. Reporting Person is the trustee of that trust. Mr. Hooven disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F7: These options were granted on June 20, 2007 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.